drugset / Trial / NCT02267733

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients

NCT02267733

Phase 1 Completed 51 enrolled Yale University
Non-randomizedParallel-groupOpen-labelPrevention

Summary

A Pilot Study utilizing high dose trivalent influenza vaccine dose in a booster dosing schedule for patients with monoclonal gammopathies stratified by disease status

Timeline

Start
2014-10
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine